Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-16-016985
Filing Date
2016-06-07
Accepted
2016-06-07 16:34:39
Documents
1
Period of Report
2016-06-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_146533166629433.html 4  
1 FORM 4 wf-form4_146533166629433.xml 4 3860
  Complete submission text file 0001628280-16-016985.txt   5316
Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 617-876-8191
GENOCEA BIOSCIENCES, INC. (Issuer) CIK: 0001457612 (see all company filings)

EIN.: 510596811 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O POLARIS VENTURE PARTNERS 1000 WINTER STREET, SUITE 3350 WALTHAM MA 02451
Business Address
Bitterman Kevin (Reporting) CIK: 0001591747 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36289 | Film No.: 161701654